Invesaro

Stocks Comparison

RadNet vs Veracyte: revenue, profit, margins and growth compared

RadNet brought in $2B of revenue in fiscal 2025, Veracyte $517.1M in fiscal 2025. Revenue changed by +11.5% at RadNet and +16.0% at Veracyte on the year before, so Veracyte grew faster. RadNet kept -0.9% of its revenue as net profit, Veracyte 12.8%.

Side by side, latest fiscal year

RDNTVCYT
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2B$517.1M
Revenue growth+11.5%+16.0%
Net income-$18.7M$66.4M
Net margin-0.9%12.8%
Free cash flown/a$126.6M
Free cash flow marginn/a24.5%
Earnings per share (diluted)-$0.25$0.82
Cash$767.2M$362.6M
Debt$1.1Bn/a
Price to earningsn/a55.4
Market value$5.6B$3.7B
Dividend yieldn/an/a
Rank by revenue in sector#108 of 523 · Health care#190 of 523 · Health care

Over the years

Revenue
RDNT FY2018: $975.1MRDNT FY2019: $1.2BRDNT FY2020: $1.1BRDNT FY2021: $1.3BRDNT FY2022: $1.4BRDNT FY2023: $1.6BRDNT FY2024: $1.8BRDNT FY2025: $2BVCYT FY2018: $92MVCYT FY2019: $120.4MVCYT FY2020: $117.5MVCYT FY2021: $219.5MVCYT FY2022: $296.5MVCYT FY2023: $361.1MVCYT FY2024: $445.8MVCYT FY2025: $517.1MFY18FY19FY20FY21FY22FY23FY24FY25
RDNT $2BVCYT $517.1M
Net income
RDNT FY2018: $32.2MRDNT FY2019: $14.8MRDNT FY2020: -$14.8MRDNT FY2021: $24.7MRDNT FY2022: $10.7MRDNT FY2023: $3MRDNT FY2024: $2.8MRDNT FY2025: -$18.7MVCYT FY2018: -$23MVCYT FY2019: -$12.6MVCYT FY2020: -$34.9MVCYT FY2021: -$75.6MVCYT FY2022: -$36.6MVCYT FY2023: -$74.4MVCYT FY2024: $24.1MVCYT FY2025: $66.4MFY18FY19FY20FY21FY22FY23FY24FY25
RDNT -$18.7MVCYT $66.4M
Net margin
RDNT FY2018: 3.3%RDNT FY2019: 1.3%RDNT FY2020: -1.4%RDNT FY2021: 1.9%RDNT FY2022: 0.7%RDNT FY2023: 0.2%RDNT FY2024: 0.2%RDNT FY2025: -0.9%VCYT FY2018: -25.0%VCYT FY2019: -10.5%VCYT FY2020: -29.7%VCYT FY2021: -34.4%VCYT FY2022: -12.3%VCYT FY2023: -20.6%VCYT FY2024: 5.4%VCYT FY2025: 12.8%FY18FY19FY20FY21FY22FY23FY24FY25
RDNT -0.9%VCYT 12.8%
Revenue growth
RDNT FY2019: +18.4%RDNT FY2020: -7.1%RDNT FY2021: +22.7%RDNT FY2022: +8.7%RDNT FY2023: +13.0%RDNT FY2024: +13.2%RDNT FY2025: +11.5%VCYT FY2019: +30.8%VCYT FY2020: -2.4%VCYT FY2021: +86.8%VCYT FY2022: +35.1%VCYT FY2023: +21.8%VCYT FY2024: +23.5%VCYT FY2025: +16.0%FY19FY20FY21FY22FY23FY24FY25
RDNT +11.5%VCYT +16.0%
Free cash flow
RDNT FY2018: $44.6MRDNT FY2019: $30.2MVCYT FY2018: -$15.4MVCYT FY2019: -$6MVCYT FY2020: -$12.5MVCYT FY2021: -$37MVCYT FY2022: -$1MVCYT FY2023: $34.3MVCYT FY2024: $63.8MVCYT FY2025: $126.6MFY18FY19FY20FY21FY22FY23FY24FY25
RDNT $30.2MVCYT $126.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about RadNet and Veracyte

Which is bigger by revenue, RadNet or Veracyte?

RadNet is bigger by revenue: $2B in fiscal 2025, against $517.1M for Veracyte in fiscal 2025.

Which keeps more of its revenue as profit, RadNet or Veracyte?

RadNet had a net margin of -0.9% in fiscal 2025; Veracyte had 12.8% in fiscal 2025.

Which grew revenue faster, RadNet or Veracyte?

In their latest fiscal years revenue changed by +11.5% at RadNet and +16.0% at Veracyte.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies